IQVIA Holdings Inc.
IndexS&P 500 P/E34.78 EPS (ttm)5.72 Insider Own0.88% Shs Outstand185.50M Perf Week5.60%
Market Cap36.95B Forward P/E16.52 EPS next Y12.04 Insider Trans-0.33% Shs Float184.29M Perf Month-7.85%
Income1.09B PEG3.00 EPS next Q2.41 Inst Own91.10% Short Float / Ratio0.95% / 1.77 Perf Quarter-4.29%
Sales14.41B P/S2.56 EPS this Y15.50% Inst Trans0.41% Short Interest1.75M Perf Half Y9.51%
Book/sh31.08 P/B6.40 EPS next Y15.40% ROA4.40% Target Price258.65 Perf Year-14.02%
Cash/sh7.05 P/C28.23 EPS next 5Y11.61% ROE19.50% 52W Range165.75 - 254.94 Perf YTD-2.93%
Dividend- P/FCF23.30 EPS past 5Y32.60% ROI8.20% 52W High-21.99% Beta1.42
Dividend %- Quick Ratio0.90 Sales past 5Y8.20% Gross Margin34.90% 52W Low19.99% ATR5.76
Employees86000 Current Ratio0.90 Sales Q/Q2.80% Oper. Margin12.50% RSI (14)47.79 Volatility1.63% 3.02%
OptionableYes Debt/Eq2.21 EPS Q/Q-26.20% Profit Margin7.60% Rel Volume0.98 Prev Close194.95
ShortableYes LT Debt/Eq2.18 EarningsFeb 10 BMO Payout0.00% Avg Volume983.62K Price198.89
Recom1.70 SMA200.20% SMA50-7.05% SMA200-6.03% Volume962,864 Change2.02%
Mar-17-23Initiated Truist Buy $265
Dec-06-22Initiated Cowen Outperform $251
Nov-17-22Downgrade Citigroup Buy → Neutral $275 → $245
Aug-25-22Initiated Credit Suisse Outperform $300
Jul-15-22Initiated SVB Leerink Outperform $256
May-24-22Initiated Guggenheim Buy $244
Apr-29-22Upgrade Piper Sandler Neutral → Overweight $231 → $255
Apr-25-22Downgrade Wells Fargo Overweight → Equal Weight $235
Aug-05-21Resumed Credit Suisse Outperform $272
Apr-16-21Upgrade Stephens Equal-Weight → Overweight $180 → $250
Show Previous Ratings
Mar-28-23 12:56PM
Mar-25-23 07:20AM
Mar-14-23 08:00AM
Mar-13-23 02:39PM
08:29PM Loading…
Mar-02-23 08:29PM
Mar-01-23 04:15PM
Feb-27-23 12:51PM
Feb-23-23 11:00AM
Feb-21-23 06:48PM
Feb-16-23 02:45PM
Feb-15-23 02:11PM
Feb-13-23 02:34PM
11:43AM Loading…
Feb-12-23 07:35AM
Feb-10-23 11:32AM
Feb-09-23 12:00PM
Feb-07-23 09:53AM
Feb-06-23 01:34PM
Feb-03-23 10:00AM
Jan-31-23 09:59AM
Jan-30-23 05:25PM
Jan-25-23 05:35PM
08:25AM Loading…
Jan-20-23 08:25AM
Jan-18-23 12:26PM
Jan-11-23 08:44AM
Jan-06-23 07:00AM
Jan-05-23 02:08PM
Jan-03-23 11:05AM
Jan-02-23 07:34AM
Dec-28-22 08:30AM
Dec-20-22 09:45AM
Dec-08-22 02:13PM
Dec-02-22 11:31AM
Nov-25-22 11:31AM
Nov-14-22 07:19AM
Nov-11-22 11:47AM
Nov-10-22 11:00AM
Oct-27-22 02:49PM
Oct-26-22 03:25PM
Oct-24-22 04:15PM
Oct-20-22 02:12PM
Oct-19-22 10:01AM
Oct-18-22 01:01PM
Oct-12-22 07:22AM
Oct-11-22 02:45PM
Oct-10-22 11:40AM
Oct-07-22 09:01AM
Oct-06-22 08:15AM
Oct-04-22 11:46AM
Oct-03-22 04:15PM
Sep-30-22 03:07PM
Sep-28-22 10:00AM
Sep-23-22 05:12PM
Sep-22-22 08:05AM
Sep-20-22 04:31PM
Sep-19-22 10:06AM
Sep-16-22 05:59PM
Sep-07-22 08:15AM
Sep-06-22 10:36AM
Sep-05-22 08:35AM
Sep-02-22 03:16PM
Sep-01-22 04:15PM
Aug-29-22 07:14PM
Aug-23-22 10:00AM
Aug-15-22 07:30AM
Aug-12-22 11:56AM
Aug-11-22 02:51PM
Aug-10-22 02:18PM
Aug-09-22 03:19PM
Aug-08-22 08:06AM
Aug-04-22 11:50AM
Aug-03-22 11:32AM
Aug-02-22 02:40PM
Jul-27-22 03:32PM
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Knightly Kevin CSee RemarksFeb 16Sale225.614,4461,003,0681,973Feb 17 05:13 PM
Sherbet EricSee RemarksFeb 14Sale230.001,000230,00017,053Feb 15 05:58 PM